Log inSign up
AAOIFI No. 21 screening

Is QNRX halal?

Quoin Pharmaceuticals, Ltd.

Not halal

Quoin Pharmaceuticals, Ltd. did not pass AAOIFI screening. The failed check is shown below.

Checked: 15 October 2026

Exchange

NASDAQ

Price

3.9

Day

-3.23%

Market cap

$19.2M

Industry

Biotechnology

Sector

Healthcare

What the company does

Quoin Pharmaceuticals develops drugs for rare skin diseases (QRX003 for Netherton syndrome), in clinical trials. No commercial product or revenue.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $0 ÷ current market cap $19.22M = 0.0%

    0.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $10.80M ÷ current market cap $19.22M = 56.2%

    56.2%

    Fail

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyQNRX's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →
Is QNRX halal? — Quoin Pharmaceuticals, Ltd. AAOIFI screening result — Limitup